Charles River Laboratories (CRL)
EBITDA Growth
-31.73%
Quarterly · Period ending:
CRL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-31.73%period ending
Latest reported-31.73%period ending
CRL Quarterly EBITDA YoY % (10.62% → -31.73%)
Year-over-year change
High-resolution chart · PNG
CRL ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 57.3187% | |
| 10.6217% |